177 related articles for article (PubMed ID: 24782504)
1. Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome.
Martínez-Trillos A; Pinyol M; Navarro A; Aymerich M; Jares P; Juan M; Rozman M; Colomer D; Delgado J; Giné E; González-Díaz M; Hernández-Rivas JM; Colado E; Rayón C; Payer AR; Terol MJ; Navarro B; Quesada V; Puente XS; Rozman C; López-Otín C; Campo E; López-Guillermo A; Villamor N
Blood; 2014 Jun; 123(24):3790-6. PubMed ID: 24782504
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characterization of chronic lymphocytic leukemia with MYD88 mutations: L265P and non-L265P mutations are associated with different features.
Shuai W; Lin P; Strati P; Patel KP; Routbort MJ; Hu S; Wei P; Khoury JD; You MJ; Loghavi S; Tang Z; Fang H; Thakral B; Medeiros LJ; Wang W
Blood Cancer J; 2020 Aug; 10(8):86. PubMed ID: 32848129
[TBL] [Abstract][Full Text] [Related]
3. Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemia.
Baer C; Dicker F; Kern W; Haferlach T; Haferlach C
Leukemia; 2017 Jun; 31(6):1355-1362. PubMed ID: 27840426
[TBL] [Abstract][Full Text] [Related]
4. MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL.
Improgo MR; Tesar B; Klitgaard JL; Magori-Cohen R; Yu L; Kasar S; Chaudhary D; Miao W; Fernandes SM; Hoang K; Westlin WF; Kim HT; Brown JR
Br J Haematol; 2019 Mar; 184(6):925-936. PubMed ID: 30537114
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
Putowski M; Podgórniak M; Piróg M; Knap J; Zaleska J; Purkot J; Zawiślak J; Zakrzewska E; Karczmarczyk A; Własiuk P; Subocz E; Giannopoulos K
Pol Arch Intern Med; 2017 Apr; 127(4):238-244. PubMed ID: 28424451
[TBL] [Abstract][Full Text] [Related]
6. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
[TBL] [Abstract][Full Text] [Related]
7. TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.
Mongini PK; Gupta R; Boyle E; Nieto J; Lee H; Stein J; Bandovic J; Stankovic T; Barrientos J; Kolitz JE; Allen SL; Rai K; Chu CC; Chiorazzi N
J Immunol; 2015 Aug; 195(3):901-23. PubMed ID: 26136429
[TBL] [Abstract][Full Text] [Related]
8. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
[TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics in Chinese with chronic lymphocytic leukemia by next-generation sequencing: A single-center retrospective analysis.
Cao Y; Chen Y; Tao T; Gong Y; Xu C; Cen J; Shen H; Pan J; Chen S; Yao L
Int J Lab Hematol; 2023 Dec; 45(6):908-916. PubMed ID: 37551448
[TBL] [Abstract][Full Text] [Related]
10. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
[TBL] [Abstract][Full Text] [Related]
11. Targeting IRAK4 disrupts inflammatory pathways and delays tumor development in chronic lymphocytic leukemia.
Giménez N; Schulz R; Higashi M; Aymerich M; Villamor N; Delgado J; Juan M; López-Guerra M; Campo E; Rosich L; Seiffert M; Colomer D
Leukemia; 2020 Jan; 34(1):100-114. PubMed ID: 31197259
[TBL] [Abstract][Full Text] [Related]
12. Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia.
Ali YB; Foad RM; Abdel-Wahed E
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3245-3250. PubMed ID: 29286214
[TBL] [Abstract][Full Text] [Related]
13. MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene.
Qin SC; Xia Y; Miao Y; Zhu HY; Wu JZ; Fan L; Li JY; Xu W; Qiao C
Blood Cancer J; 2017 Dec; 7(12):651. PubMed ID: 29242635
[No Abstract] [Full Text] [Related]
14. A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
Hernández JÁ; Hernández-Sánchez M; Rodríguez-Vicente AE; Grossmann V; Collado R; Heras C; Puiggros A; Martín AÁ; Puig N; Benito R; Robledo C; Delgado J; González T; Queizán JA; Galende J; de la Fuente I; Martín-Núñez G; Alonso JM; Abrisqueta P; Luño E; Marugán I; González-Gascón I; Bosch F; Kohlmann A; González M; Espinet B; Hernández-Rivas JM;
PLoS One; 2015; 10(11):e0143073. PubMed ID: 26630574
[TBL] [Abstract][Full Text] [Related]
15. Genetic and Clinical Characteristics of Korean Chronic Lymphocytic Leukemia Patients with High Frequencies of
Ahn A; Kim HS; Kim TY; Lee JM; Kang D; Yu H; Lee CY; Kim Y; Eom KS; Kim M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834590
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of MYD88 mutations in CLL: the jury is still out.
Baliakas P; Hadzidimitriou A; Agathangelidis A; Rossi D; Sutton LA; Kminkova J; Scarfo L; Pospisilova S; Gaidano G; Stamatopoulos K; Ghia P; Rosenquist R
Blood; 2015 Aug; 126(8):1043-4. PubMed ID: 26294719
[No Abstract] [Full Text] [Related]
17. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
[TBL] [Abstract][Full Text] [Related]
18. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
[TBL] [Abstract][Full Text] [Related]
19. Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.
Morabito F; Mosca L; Cutrona G; Agnelli L; Tuana G; Ferracin M; Zagatti B; Lionetti M; Fabris S; Maura F; Matis S; Gentile M; Vigna E; Colombo M; Massucco C; Recchia AG; Bossio S; De Stefano L; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Tassone P; Negrini M; Monti S; Rossi D; Gaidano G; Ferrarini M; Neri A
Clin Cancer Res; 2013 Nov; 19(21):5890-900. PubMed ID: 24036852
[TBL] [Abstract][Full Text] [Related]
20. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
